Íomhá chlúdaigh

Effect of percutaneous coronary intervention in diabetic patients with non-ST elevated myocardial infarction

<p>Background: Diabetic patients with Non ST Elevated Myocardial Infarction (NSTEMI) are at high risk for subsequent cardiovascular events. But, early Percutaneous Coronary Intervention (PCI) in high risk group of NSTEMI patients significantly prove the primary outcomes. </p><p>Obj...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	MSI Tipu Chowdhury (Údar), Sadia Sultana (Údar), MD. Syedul Alam Kuryshi (Údar), Zahidul Mostafa (Údar), Mohammad Khurshadul Alam (Údar)
Formáid:	LEABHAR
Foilsithe / Cruthaithe:	Journal of Cardiovascular Medicine and Cardiology - Peertechz Publications, 2021-02-23.
Ábhair:	Research Article
Rochtain ar líne:	Connect to this object online.
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

THE RELATIONSHIP OF GENDER WITH IMMEDIATE RESULTS OF PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION
de réir: N. Netyazhenko, et al.
Foilsithe / Cruthaithe: (2015)

Predictors of contrast-induced nephropathy in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention
de réir: Mohamed Abdel-Ghany, et al.
Foilsithe / Cruthaithe: (2021)

Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
de réir: Göksel Çinier, et al.
Foilsithe / Cruthaithe: (2020)

REPERFUSION MYOCARDIAL INJURY AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION. CLINICAL OBSERVATION
de réir: N. A. Kosheleva, et al.
Foilsithe / Cruthaithe: (2016)

Impact of Stress Hyperglycemia on No-Reflow Phenomenon in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
de réir: Mohamed Khalfallah, et al.
Foilsithe / Cruthaithe: (2022)

Renoprotective effect of remote ischemic postconditioning in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
de réir: Cao B, et al.
Foilsithe / Cruthaithe: (2018)

PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
de réir: Wu ZF, et al.
Foilsithe / Cruthaithe: (2023)

Glycoprotein IIb/IIIa Receptor Inhibitors in Patients with ST-Segment Elevation Myocardial Infarction and Primary Percutaneous Coronary Intervention
de réir: A. S. Tereshchenko, et al.
Foilsithe / Cruthaithe: (2020)

In-hospital outcomes of angiography versus intravascular ultrasound-guided percutaneous coronary intervention in ST-elevation myocardial infarction patients
de réir: Mazin Khalid, et al.
Foilsithe / Cruthaithe: (2020)

Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
de réir: Mohamed Khalfallah, et al.
Foilsithe / Cruthaithe: (2021)

Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
de réir: Ming Gao, et al.
Foilsithe / Cruthaithe: (2020)

Prognostic Value of Pentraxin-3 Change After Primary Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction
de réir: Li SY, et al.
Foilsithe / Cruthaithe: (2023)

Clinical Manifestation of Cardiac Rupture in Patients with ST-Segment Elevation Myocardial Infarction: Early Versus Late Primary Percutaneous Coronary Intervention
de réir: Xile Bi, et al.
Foilsithe / Cruthaithe: (2022)

Cardioprotective Effects of Coenzyme Q10 Supplementation on Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
de réir: Amirhossein Yazdi, et al.
Foilsithe / Cruthaithe: (2023)

The Time Profile of Pentraxin 3 in Patients with Acute ST-Elevation Myocardial Infarction and Stable Angina Pectoris Undergoing Percutaneous Coronary Intervention
de réir: Ragnhild Helseth, et al.
Foilsithe / Cruthaithe: (2014)

Relationship between the extent of coronary artery disease and in-stent restenosis in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
de réir: Erkan Yıldırım, et al.
Foilsithe / Cruthaithe: (2017)

The optimal percutaneous coronary intervention strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis
de réir: Meng-Jin Hu, et al.
Foilsithe / Cruthaithe: (2022)

Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
de réir: Wang M, et al.
Foilsithe / Cruthaithe: (2015)

Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction
de réir: Mohamed Hassan Nab, et al.
Foilsithe / Cruthaithe: (2019)

Potential role of Vitamin C intracoronary administration in preventing cardiac injury after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction
de réir: Negar Shafaei-Bajestani, et al.
Foilsithe / Cruthaithe: (2019)

Elevated Serum Uric Acid/Albumin Ratio as a Predictor of Post-Contrast Acute Kidney Injury After Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction
de réir: Zhang Y, et al.
Foilsithe / Cruthaithe: (2022)

Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry
de réir: Mohammad Zubaid, et al.
Foilsithe / Cruthaithe: (2020)

A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction
de réir: Enfa Zhao, et al.
Foilsithe / Cruthaithe: (2020)

Evaluation of door-to-balloon time for performing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients transferred by pre-hospital emergency system in Tehran
de réir: Leili Yekefallah, et al.
Foilsithe / Cruthaithe: (2019)

The relationship between visible thrombus aspiration material with no-reflow and in-hospital mortality ratio in patients with anterior ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
de réir: Taner Şeker, et al.
Foilsithe / Cruthaithe: (2019)

Prognostic Implications of the Admission Cardiac Troponin I Levels and Door-to-Balloon Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
de réir: Zhao L, et al.
Foilsithe / Cruthaithe: (2022)

The use of percutaneous coronary intervention in black and white veterans with acute myocardial infarction
de réir: Sales Anne E, et al.
Foilsithe / Cruthaithe: (2006)

Reply to Entitled -The relationship between visible thrombus aspiration material with no-reflow and in-hospital mortality ratio in patients with anterior ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
de réir: Taner Şeker, et al.
Foilsithe / Cruthaithe: (2019)

Plasma Granzyme B in ST Elevation Myocardial Infarction versus Non-ST Elevation Acute Coronary Syndrome: Comparisons with IL-18 and Fractalkine
de réir: Hala O. El-Mesallamy, et al.
Foilsithe / Cruthaithe: (2013)

DETERMINANTS OF MYOCARDIAL INFARCTION OUTCOMES IN A NON-PERCUTANEOUS CORONARY INTERVENTION HOSPITAL IN JAKARTA
de réir: Talitha Syifa Laili, et al.
Foilsithe / Cruthaithe: (2023)

Association of Different Lactate Indices with 30-Day and 180-Day Mortality in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: A Retrospective Cohort Study
de réir: Hu L, et al.
Foilsithe / Cruthaithe: (2020)

Significance of Multiple Lymphocyte-to-C-Reactive Protein Ratios in Predicting Long-Term Major Cardiovascular Adverse Events in Emergency Percutaneous Coronary Intervention Patients with ST-Segment Elevation Myocardial Infarction
de réir: Ye J, et al.
Foilsithe / Cruthaithe: (2024)

Unique role of admission hyperglycemia on myocardial infarction size and area at risk following an acute ST-elevation myocardial infarction
de réir: Taghreed Sayed Meshref, et al.
Foilsithe / Cruthaithe: (2020)

Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis
de réir: Dai W, et al.
Foilsithe / Cruthaithe: (2018)

Persistent ST Segment Elevation After Repeated Percutaneous Coronary Intervention: A Dressler Syndrome?
de réir: Eka Ginanjar, et al.
Foilsithe / Cruthaithe: (2022)

Characterization of patients with acute myocardial infarction with ST segment elevation
de réir: Miguel R. Franco Terrero, et al.
Foilsithe / Cruthaithe: (2015)

Filtering electrocardiogram: Music, math, and ST-elevation myocardial infarction
de réir: Emre K. Aslanger, et al.
Foilsithe / Cruthaithe: (2021)

Intramuscular Epinephrine-Induced Transient ST-Elevation Myocardial Infarction
de réir: Binav Shrestha MBBS, et al.
Foilsithe / Cruthaithe: (2018)

Machine learning for prediction of bleeding in acute myocardial infarction patients after percutaneous coronary intervention
de réir: Xueyan Zhao, et al.
Foilsithe / Cruthaithe: (2023)

Association of Systemic Inflammatory Response Index and Pan-Immune-Inflammation-Value with Long-Term Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention
de réir: Liu Y, et al.
Foilsithe / Cruthaithe: (2023)